The Methodist Hospital Research Institute
4 clinical trials · 4 recruiting · OTHER
Trials by The Methodist Hospital Research Institute
RECRUITINGPhase 2NCT07383649
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
This is a phase II trial with an initial safety lead-in evaluating the efficacy, safety, neurocognitive, and quality-of-life outcomes of anti-cytomegalovirus (CMV) therapy and...
Sponsor: The Methodist Hospital Research InstituteEnrolling: 281 location
Brain Cancer MetastaticCMV Viremia
RECRUITINGPhase 1 / Phase 2NCT06536413
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
This is a Phase IB/II trial that will investigate the safety, tolerability and efficacy of combination therapy using All-Trans Retinoic Acid (ATRA) with Carfilzomib based...
Sponsor: The Methodist Hospital Research InstituteEnrolling: 421 location
Multiple Myeloma
RECRUITINGNCT06072703
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Neurogenic overactive bladder (NOAB), characterized by urinary frequency, urgency or urgency incontinence symptoms occurring during the storage phase of the bladder, is the most...
Sponsor: The Methodist Hospital Research InstituteEnrolling: 291 location
Neurogenic BladderMultiple SclerosisOveractive Bladder
RECRUITINGNCT06782100
MRI Guided Management of Occlusive Peripheral Arterial Disease
The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize...
Sponsor: The Methodist Hospital Research InstituteEnrolling: 1751 location
Peripheral Vascular Diseases